News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland
Tuesday, August 30, 2022Horizon Therapeutics plc has announced the submission of a planning application to expand its development and manufacturing facility in Waterford Ireland The expansion aims to include new capabilities for drug substance biologics development and manu...
ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP
Tuesday, August 30, 2022ANI Pharmaceuticals Inc today announced the launch of Prochlorperazine Maleate Tablets USP mg and mg ANIs Prochlorperazine Maleate Tablets USP mg and mg are the generic version of the Reference Listed Drug RLD Compazine and were developed in tech...
European Commission Approves FYB201/Ranivisio® (Ranivisio - Ranibizumab), a Biosimilar to Lucentis®
Monday, August 29, 2022Polpharma Biologics Group BV Formycon AG and Bioeq AG have announced that the European Commission EC has granted marketing authorization MA for Ranivisio Ranivisio Ranibizumab a biosimilar to Lucentis ranibizumabinjection in the European Union EU Th...
Biocytogen Expands Partnership with Merck
Friday, August 26, 2022Biocytogen Pharmaceuticals Beijing Co Ltd Biocytogen and Merck have entered into a global licensing agreement for the use of Biocytogens RenMice platform
GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical Development
Thursday, August 25, 2022GNS a leading company in the field of biopharmaceutical drug discovery and development using Digital Twins and Causal AI biosimulation technology has announced a collaboration with Servier a global pharmaceutical group to advance efforts in Multiple...
LumaBridge and Parker Institute for Cancer Immunotherapy Announce Strategic Alliance to Streamline Immunotherapy Development
Thursday, August 25, 2022LumaBridge formerly known as Cancer Insight a clinical research organization CRO dedicated to discovering developing and testing emerging biotechnologies related to cancer therapies and the Parker Institute for Cancer Immunotherapy PICI the largest n...
Roche launches a digital PCR system, a powerful new diagnostics platform in the fight against cancer and other diseases
Wednesday, August 24, 2022Roche has unveiled the Digital LightCycler System their first digital polymerase chain reaction PCR system This advanced system is specifically designed to detect diseases and accurately quantify minuscule amounts of specific DNA and RNA targets that...
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
Wednesday, August 24, 2022Pfizer Inc and BioNTech SE announced updated efficacy results from a Phase trial evaluating a three g dose series of the PfizerBioNTech COVID Vaccine
Translational Research Describes an Epigenetic Approach for Regulating Fear-Memory
Tuesday, August 23, 2022EpiVario Inc an emerging biotech company dedicated to developing innovative therapeutics for memoryrelated psychiatric disorders has announced significant preclinical research findings that have the potential to lead to a treatment approach for PostT...
Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT
Tuesday, August 23, 2022Vaderis Therapeutics AG a clinical stage biotechnology company specializing in treatments for rare diseases associated with vascular malformations has emerged from stealth mode and commenced its INSIGHT proofofconcept clinical trial This trial focuse...
